President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
President Joe Biden said Tuesday that the U.S. will begin to impose sanctions on Russia, calling recent troop movement into Ukraine an 'invasion.' Biden and other government officials including from the State Department have begun to classify the Russian troop movement as an invasion after Russian President Vladimir Putin ordered troops to two independent Ukrainian areas in an alleged "peacekeeping" mission — which the West considers an act of aggression. Biden said Russia will continue to pay 'an even steeper price' if it continues sending troops into Ukraine. What happens next? Will Putin find a way around these sanctions? Ariel Cohen, senior fellow at the Atlantic Council, joins Closing Bell to discuss Biden's remarks, how the West will protect Ukraine since it doesn't belong to NATO, and more.
Russian lawmakers have given President Vladimir Putin a military force authorization in Ukraine, and President Biden has described Putin's announcement declaring the independence of two provinces within Ukraine and his subsequent deployment of peacekeepers as tantamount to "invasion. David Tafuri, a former Obama campaign foreign policy advisor and Bush State Department official, joined Cheddar News to discuss. "The Ukrainian military occupies more than 70 percent of those provinces still," Tafuri said, noting Putin alleged having a responsibility to defend those regions. "This would put Ukrainian forces and Russian forces right at each other engaged. And that might be how the war starts."
The major indexes ended Tuesday's session sharply lower due to escalating tensions between Russia and Ukraine. Bill Stone, Chief Investment Officer at The Glenview Trust Company, joins Cheddar News' Closing Bell, where he reminds viewers that Wall Street doesn't like uncertainty, and more of the recent losses are due to geopolitics than inflation.
Karim Hijazi, CEO of Prevailion, joins Cheddar News' Closing Bell, where he says that crypto's decentralized nature will pose obstacles for the FBI's new crypto unit, but it will also make progress with items such as managing fraudulent exchanges.
The Retail Industry Leaders Association released a report alleging the safety risks, economic losses, and potential job losses they link to a surge in shoplifting crimes in the United States. Lisa LaBruno, senior EVP of retail operations at the trade organization, joined Cheddar News to discuss the impact of websites that allow for the resale of unverified goods and passing the INFORM Consumers Act to stamp it out. “We need to hold the online marketplaces accountable for being a favored venue for criminals to resell stolen product," LaBruno said. "And that is exactly what the INFORM Act is designed to do."
The East-West faceoff over Ukraine has escalated dramatically, with Russian lawmakers authorizing President Vladimir Putin to use military force outside his country and President Biden and European leaders responding by slapping sanctions on Russian oligarchs and banks.
Stocks closed broadly lower Tuesday after Russia sent forces into Ukraine’s eastern region and the U.S., European Union and U.K. responded with economic sanctions.
